Daylight saving time ended in US
Daylight Saving Time (United States) began Sunday, March 11, 2012, 2:00am, and ended Sunday, November 4, 2012, 2:00am. Daylight saving time (DST) — also summer time in several countries in … continue reading
Daylight Saving Time (United States) began Sunday, March 11, 2012, 2:00am, and ended Sunday, November 4, 2012, 2:00am. Daylight saving time (DST) — also summer time in several countries in … continue reading
Planning to cap off your Halloween costume with a pair of cat-eye contact lenses? The Federal Trade Commission wants you to know that all contacts — even those that are cosmetic or theatrical — require a prescription.
CBM President Professor Allen Foster met with the Director-General Dr Margaret Chan, for the World Health Organizations global initiative to eliminate avoidable blindness “Vision 2020: The Right to Sight” on the eve of World Sight Day 2007 at WHO Headquarters Geneva.
Eating fewer refined carbohydrates may slow the progression of age-related macular degeneration (AMD), according to a new study from researchers at the Jean Mayer USDA Human Nutrition Research Center on Aging at Tufts University.
An interdisciplinary team of biomedical researchers from the USC Viterbi School, the College and the Keck School of Medicine of USC has received a $6-million Bioengineering Research Partnership grant from the National Institutes of Health (NIH) to begin designing visual aids for millions of older adults who suffer from significant vision loss.
Phylonix Pharmaceuticals, Inc. today announced that it has been awarded a $1,092,031 Phase II Small Business Innovation Grant (SBIR) from the National Eye Institute of the National Institutes of Health (NIH) to develop zebrafish eye disease models for drug screening. The grant for “New Models for Eye Diseases” will support the Phylonix program over a period of three years.
Most clinical trials for new diabetes drugs do not consider the impact medication will have on a patient’s quality of life or other outcomes that are important to patients, such as the risk of developing complications associated with diabetes, according to a Mayo Clinic commentary in the current issue of The Lancet.
Uncontrolled patients with type 2 diabetes treated with metformin, one of the most prescribed oral medicines for this disease, were four times more likely to achieve recommended blood sugar control levels by adding Galvus® (vildagliptin) to their treatment compared to those who added a placebo, according to new clinical data[1].
Prof. Ehud Assia, of Tel Aviv University?s Sackler School of Medicine is, quite simply, a rock star in the field of eye surgery. One of a small number of surgeons in the world who currently perform a complicated form of glaucoma surgery, Prof. Assia has developed a novel laser device that promises to revolutionize treatment of the disease.
Consuming higher levels of the yellow plant pigments lutein and zeaxanthin may be associated with a lower risk for age-related macular degeneration, according to a report in the September issue of Archives of Ophthalmology, one of the JAMA/Archives journals.